Featured article

Zedsen closes $12m Series B and appoints Dr Caroline Hargrove as CTO to develop non-invasive biosensor

Company Zedsen, who have recently closed $12m Series B, is a UK company developing breakthrough non-invasive technology that helps consumers understand their health based on data coming from their bloodstream, is on a mission to make true, continuous proactive health a reality for everyone by helping people understand the inner workings of their bodies so […]

Read article